Citadel Advisors’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Buy |
+66,900
| New | +$1.28M | ﹤0.01% | 7167 |
|
|
2025
Q4 | – | Sell |
-14,900
| Closed | -$400K | – | 14016 |
|
|
2025
Q3 | $400K | Sell |
14,900
-20,700
| -58% | -$494K | ﹤0.01% | 9669 |
|
|
2025
Q2 | $597K | Sell |
35,600
-63,000
| -64% | -$1.11M | ﹤0.01% | 8219 |
|
|
2025
Q1 | $1.74M | Buy |
98,600
+32,400
| +49% | +$650K | ﹤0.01% | 5803 |
|
|
2024
Q4 | $1.61M | Sell |
66,200
-29,100
| -31% | -$831K | ﹤0.01% | 6081 |
|
|
2024
Q3 | $3.54M | Buy |
95,300
+46,700
| +96% | +$1.74M | ﹤0.01% | 4506 |
|
|
2024
Q2 | $2.31M | Buy |
48,600
+1,600
| +3% | +$70.1K | ﹤0.01% | 5043 |
|
|
2024
Q1 | $1.8M | Buy |
47,000
+26,300
| +127% | +$855K | ﹤0.01% | 5729 |
|
|
2023
Q4 | $646K | Sell |
20,700
-33,100
| -62% | -$1.19M | ﹤0.01% | 7554 |
|
|
2023
Q3 | $2.16M | Buy |
53,800
+6,700
| +14% | +$314K | ﹤0.01% | 5073 |
|
|
2023
Q2 | $2.48M | Sell |
47,100
-10,200
| -18% | -$621K | ﹤0.01% | 4790 |
|
|
2023
Q1 | $3.66M | Buy |
57,300
+29,400
| +105% | +$1.92M | ﹤0.01% | 4327 |
|
|
2022
Q4 | $1.35M | Sell |
27,900
-64,100
| -70% | -$4.02M | ﹤0.01% | 6235 |
|
|
2022
Q3 | $6.49M | Buy |
92,000
+56,300
| +158% | +$4.82M | ﹤0.01% | 3446 |
|
|
2022
Q2 | $2.53M | Sell |
35,700
-3,400
| -9% | -$219K | ﹤0.01% | 5074 |
|
|
2022
Q1 | $3.12M | Sell |
39,100
-57,800
| -60% | -$4.3M | ﹤0.01% | 5081 |
|
|
2021
Q4 | $8.85M | Sell |
96,900
-35,400
| -27% | -$3.8M | ﹤0.01% | 3277 |
|
|
2021
Q3 | $17M | Buy |
132,300
+16,000
| +14% | +$2.24M | ﹤0.01% | 2240 |
|
|
2021
Q2 | $17.7M | Buy |
116,300
+46,900
| +68% | +$6.18M | ﹤0.01% | 2228 |
|
|
2021
Q1 | $7.32M | Sell |
69,400
-16,700
| -19% | -$1.67M | ﹤0.01% | 3492 |
|
|
2020
Q4 | $6.82M | Buy |
86,100
+51,500
| +149% | +$3.77M | ﹤0.01% | 3162 |
|
|
2020
Q3 | $1.96M | Sell |
34,600
-22,200
| -39% | -$1.2M | ﹤0.01% | 4753 |
|
|
2020
Q2 | $3.5M | Buy |
56,800
+40,900
| +257% | +$1.67M | ﹤0.01% | 3607 |
|
|
2020
Q1 | $513K | Buy |
15,900
+6,600
| +71% | +$222K | ﹤0.01% | 6423 |
|
|
2019
Q4 | $327K | Sell |
9,300
-10,500
| -53% | -$346K | ﹤0.01% | 7457 |
|
|
2019
Q3 | $510K | Buy |
19,800
+5,400
| +38% | +$164K | ﹤0.01% | 6712 |
|
|
2019
Q2 | $423K | Buy |
14,400
+2,600
| +22% | +$75.1K | ﹤0.01% | 7070 |
|
|
2019
Q1 | $403K | Buy |
+11,800
| New | +$417K | ﹤0.01% | 7154 |
|
|
2018
Q4 | – | Sell |
-14,800
| Closed | -$710K | – | 9729 |
|
|
2018
Q3 | $710K | Sell |
14,800
-6,500
| -31% | -$266K | ﹤0.01% | 6138 |
|
|
2018
Q2 | $660K | Buy |
+21,300
| New | +$498K | ﹤0.01% | 5920 |
|
|
2015
Q3 | – | Sell |
-1,000
| Closed | -$10K | – | 9219 |
|
|
2015
Q2 | $10K | Buy |
+1,000
| New | +$9.27K | ﹤0.01% | 8406 |
|
|
2015
Q1 | – | Sell |
-6,400
| Closed | -$58K | – | 8833 |
|
|
2014
Q4 | $58K | Buy |
6,400
+400
| +7% | +$3.87K | ﹤0.01% | 7085 |
|
|
2014
Q3 | $64K | Buy |
6,000
+1,400
| +30% | +$16.6K | ﹤0.01% | 6749 |
|
|
2014
Q2 | $77K | Buy |
+4,600
| New | +$75.7K | ﹤0.01% | 6433 |
|
Other funds holding STAA
BC
YC
MAP
VPM
VCM
AIM
Citadel Advisors's STAA Position: Q1 2026 in Review
Citadel Advisors increased its STAAR Surgical (STAA) stake by 416% in Q1 2026, buying an estimated $16.3M and bringing the position to 1,059,428 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2354.
Citadel Advisors first reported a position in STAA in Q4 2013 and has held it in 39 quarters since. The position peaked at $38M in Q3 2023. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.
- Citadel Advisors held 1,059,428 shares of STAAR Surgical worth $19.8M as of Q1 2026.
- Citadel Advisors bought 854,309 STAAR Surgical shares in Q1 2026, an estimated $16.3M.
- STAAR Surgical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2354 holding.
- Citadel Advisors first reported a position in STAAR Surgical in Q4 2013 and has held it in 39 quarters since.
- Citadel Advisors's STAAR Surgical position peaked at $38M in Q3 2023.
- 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.